Group One Trading’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$323K Sell
4,803
-555
-10% -$41.2K ﹤0.01% 3735
2025
Q4
$423K Buy
+5,358
New +$365K ﹤0.01% 3689
2025
Q2
Sell
-3,627
Closed -$50.7K 8250
2025
Q1
$50.7K Buy
3,627
+3,483
+2,419% +$47.3K ﹤0.01% 5146
2024
Q4
$2.22K Hold
144
﹤0.01% 6709
2024
Q3
$2.25K Hold
144
﹤0.01% 6114
2024
Q2
$2.04K Buy
+144
New +$2.25K ﹤0.01% 6222

Other funds holding INBX

Group One Trading's INBX Position: Q1 2026 in Review

Group One Trading reduced its Inhibrx (INBX) stake by 10% in Q1 2026, selling an estimated $41.2K and leaving 4,803 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #3735.

Group One Trading first reported a position in INBX in Q2 2024 and has held it in 6 quarters since. The position peaked at $423K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Group One Trading held 4,803 shares of Inhibrx worth $323K as of Q1 2026.
  • Group One Trading sold 555 Inhibrx shares in Q1 2026, an estimated $41.2K.
  • Inhibrx made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3735 holding.
  • Group One Trading first reported a position in Inhibrx in Q2 2024 and has held it in 6 quarters since.
  • Group One Trading's Inhibrx position peaked at $423K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.